These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9623740)

  • 61. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
    Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
    Salvi M; Bingoye F; Chung F; Wall JR
    J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carotid cavernous fistula in a patient with Graves' ophthalmopathy.
    Loré F; Polito E; Cerase A; Bracco S; Loffredo A; Pichierri P; Talidis F
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3487-90. PubMed ID: 12915622
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radiotherapy for Graves' ophthalmopathy: current treatment recommendations.
    McDougall IR; Donaldson SS
    Front Radiat Ther Oncol; 2001; 35():57-64. PubMed ID: 11351953
    [No Abstract]   [Full Text] [Related]  

  • 65. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
    Koshiyama H; Koh T; Fujiwara K; Hayakawa K; Shimbo S; Misaki T
    Thyroid; 1994; 4(4):409-13. PubMed ID: 7711503
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Radiotherapy for thyroid-associated orbitopathy.
    Kahaly GJ; Roesler HP; Kutzner J; Pitz S; Müller-Forell W; Beyer J; Mann W
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S201-7. PubMed ID: 10614923
    [No Abstract]   [Full Text] [Related]  

  • 69. Effect of 131 iodine therapy on the course of Graves' ophthalmopathy: a quantitative analysis of extraocular muscle volumes using orbital magnetic resonance imaging.
    Gupta MK; Perl J; Beham R; Sheeler LR; Foster JA; Gliga M; Mcbride N; Faiman MR; Mehta AE; Dattatreya R; Faiman C
    Thyroid; 2001 Oct; 11(10):959-65. PubMed ID: 11716044
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results].
    Pitz S; Kahaly G; Rösler HP; Krummenauer F; Wagner B; Stübler M; Pfeiffer N
    Klin Monbl Augenheilkd; 2002 Dec; 219(12):876-82. PubMed ID: 12548473
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Retinopathy after irradiation for Graves' ophthalmopathy.
    Nikoskelainen E; Joensuu M
    Lancet; 1989 Sep; 2(8664):690-1. PubMed ID: 2570949
    [No Abstract]   [Full Text] [Related]  

  • 72. Plasma leptin concentrations in patients with Graves' disease with or without ophthalmopathy.
    Ozata M; Uckaya G; Bolu E; Corapcioglu D; Bingol N; Ozdemir IC
    Med Sci Monit; 2001; 7(4):696-700. PubMed ID: 11433197
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy.
    Blank LE; Barendsen GW; Prummel MF; Stalpers L; Wiersinga W; Koornneel L
    Radiother Oncol; 1996 Aug; 40(2):187-9. PubMed ID: 8884975
    [No Abstract]   [Full Text] [Related]  

  • 74. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
    Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ
    Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduction by orbital radiation of cumulative doses of glucocorticoids in patients with Graves'-Basedow ophthalmopathy.
    Schaaf L; Rominger-Seyrich D; Grossmann E; Geissler W; Eggstein M; Seif FJ
    Dev Ophthalmol; 1989; 20():155-8. PubMed ID: 2591624
    [No Abstract]   [Full Text] [Related]  

  • 76. Graves' ophthalmopathy.
    Frueh BR
    Arch Ophthalmol; 1985 Aug; 103(8):1110, 1112. PubMed ID: 3839664
    [No Abstract]   [Full Text] [Related]  

  • 77. Radiotherapy of Graves' ophthalmopathy.
    Ellis DS
    Int J Radiat Oncol Biol Phys; 1992; 23(1):253-4. PubMed ID: 1572825
    [No Abstract]   [Full Text] [Related]  

  • 78. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy.
    Miller ML; Goldberg SH; Bullock JD
    Am J Ophthalmol; 1991 Nov; 112(5):600-1. PubMed ID: 1951605
    [No Abstract]   [Full Text] [Related]  

  • 79. Pituitary and orbital roentgen therapy in the hyperophthalmopathic type of Graves' disease.
    GEDDA PO; LINDGREN M
    Acta radiol; 1954 Sep; 42(3):211-20. PubMed ID: 13206823
    [No Abstract]   [Full Text] [Related]  

  • 80. Graves' ophthalmopathy.
    Glaser JS
    Arch Ophthalmol; 1984 Oct; 102(10):1448-9. PubMed ID: 6548372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.